Recente wetenschappelijke publicaties

  • Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis.

  • Auteurs Hanin A, Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel CM, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Wainwright MS, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ
  • Auteurs (entité) Gaspard Nicolas
  • Revue Epilepsia
  • Date de publication 2024-06
Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis.

  • Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis.

  • Auteurs Hanin A, Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel CM, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Wainwright MS, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ
  • Auteurs (entité) Damien Charlotte
  • Revue Epilepsia
  • Date de publication 2024-06
Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis.

  • Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study.

  • Auteurs Van Laethem JL, Borbath I, Prenen H, Geboes KP, Lambert A, Mitry E, Cassier PA, Blanc JF, Pilla L, Batlle JF, Garrote MR, Pazo-Cid RA, Gallego I, Smith KE, Ellmark P, Pico de Coaña Y, Ambarkhane SV, Macarulla T
  • Auteurs (entité) Van Laethem Jean-Luc
  • Revue Lancet Oncol
  • Date de publication 2024-05
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study.

  • Expertise in surgical neuro-oncology. Results of a survey by the EANS neuro-oncology section.

  • Auteurs Gousias K, Hoyer A, Mazurczyk LA, Bartek J, Bruneau M, Celtikci E, Foroglou N, Freyschlag C, Grossman R, Jungk C, Metellus P, Netuka D, Rola R, Schucht P, Senft C, Signorelli F, Vincent AJPE, Simon M
  • Auteurs (entité) Gilis Nathalie
  • Revue Brain Spine
  • Date de publication 2024-01
Expertise in surgical neuro-oncology. Results of a survey by the EANS neuro-oncology section.
Bordet hospital

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet

Wetenschappelijke publicaties van Jules Bordet
Erasme hospital

Erasmusziekenhuis

Bekijk alle wetenschappelijke publicaties van Erasmus

Wetenschappelijke publicaties van Erasmus
Huderf hospital

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Wetenschappelijke publicaties van het Koningin Fabiola-Kinderziekenhuis